Adult central nervous system tumors

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Adult central nervous system tumors

Introduction For both primary and metastatic brain tumors, radiation therapy (RT) remains one of the standard treatment modalities. Although RT techniques using photons have greatly improved in recent decades, substantial…

read more

Immobilization and simulation

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Immobilization and simulation

Introduction Intensity-modulated proton therapy (IMPT) using pencil beam scanning (PBS) technology is advancing rapidly for delivering precise and more conformal doses to target volumes while sparing surrounding normal and critical…

read more

Principles of proton beam therapy

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Principles of proton beam therapy

Introduction The potential of physical characteristics of protons for cancer treatments was first recognized by Wilson in 1946. During the following four decades or so, proton accelerators at various physics…

read more

Principles of radiobiology

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Principles of radiobiology

Introduction Radiotherapy is used as one of the major treatment modalities for patients with malignant diseases at different disease stages. Currently, the most common radiation choice for the majority of…

read more

Lung cancer

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Lung cancer

Introduction Lung cancer is one of the most common malignancies, accounting for approximately 234,000 new cases and 160,000 deaths per year in the United States. Treatment for lung cancer depends…

read more

Proton therapy for hematologic malignancies

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Proton therapy for hematologic malignancies

Introduction As early as the 1970s, proton therapy was considered a promising treatment for hematologic malignancies, specifically for use in total nodal irradiation, the historic standard of care treatment for…

read more

Proton therapy and sarcomas

Jan 3, 2021 by in NUCLEAR MEDICINE Comments Off on Proton therapy and sarcomas

Introduction Sarcomas are a rare and heterogenous group of malignant tumors that arise from soft tissues or bone. They constitute less than 1% of all adult malignancies and approximately 12%…

read more
Get Clinical Tree app for offline access